Literature DB >> 17136736

Recent progress in polar stationary phases for CEC.

Junjie Ou1, Jing Dong, Xiaoli Dong, Zhiyuan Yu, Mingliang Ye, Hanfa Zou.   

Abstract

This review summarizes most of the recent developments in the preparation and application of polar stationary phases for CEC covering the literature published since the year 2004. These polar stationary phases have been adopted for separation of analytes by the modes of packing column CEC, open-tubular CEC (o-CEC) and monolithic column CEC. Currently, development of o-CEC using biomolecules, such as protein and DNA, as the immobilized ligands is highlighted partly due to the simplicity of preparation. Furthermore, monolithic columns have been extended quickly, particularly inorganic materials-based monoliths, such as silica, zirconia, hafnium, etc., as an alternative to packed columns have been developed quickly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17136736     DOI: 10.1002/elps.200600298

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  4 in total

1.  Synthesis of a poly(sulfobetaine-co-polyhedral oligomeric silsesquioxane) hybrid monolith via an in-situ ring opening quaternization for use in hydrophilic interaction capillary liquid chromatography.

Authors:  Wangming Tan; Ye Chen; Xiyue Xiong; Si Huang; Zhengfa Fang; Yingzhuang Chen; Ming Ma; Bo Chen
Journal:  Mikrochim Acta       Date:  2020-01-08       Impact factor: 5.833

Review 2.  CEC: selected developments that caught my eye since the year 2000.

Authors:  Frantisek Svec
Journal:  Electrophoresis       Date:  2009-06       Impact factor: 3.535

3.  A Novel Open Tubular Capillary Electrochromatographic Method for Differentiating the DNA Interaction Affinity of Environmental Contaminants.

Authors:  Lucia D'Ulivo; Yong-Lai Feng
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

Review 4.  Recent developments in CE and CEC of peptides.

Authors:  Václav Kasicka
Journal:  Electrophoresis       Date:  2008-01       Impact factor: 3.535

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.